Mehmet Asim Bilen MD

School/Division:

Other Affiliations:

No affiliations have been saved.

External Links (e.g. Departmental web site, iTunes lectures, etc.):

No external links have been saved.

Degrees Held:

No degrees have been saved.

Research Interests:

No research interests have been saved.

Biography/Description of Research:

No biography information has been saved.

Works 1-10 of 45

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Article

High throughput, label-free isolation of circulating tumor cell clusters in meshed microwells

by Mert Boya; Tevhide Ozkaya-Ahmadov; Brandi E. Swain; Chia-Heng Chu; Norh Asmare; Ozgun Civelekoglu; Ruxiu Liu; Dohwan Lee; Sherry Tobia; Shweta Biliya; L. DeEtte McDonald; Bassel Nazha; Omer Kucuk; Martin Sanda; Benedict B. Benigno; Carlos Moreno; Mehmet Bilen; John F. McDonald; A. Faith Sarioglu

2022

Article

Bempegaldesleukin plus nivolumab in first-line renal cell carcinoma: results from the PIVOT-02 study

by Mehmet Bilen; NM Tannir; DC Cho; A Diab; M Sznol; A Balar; G Grignani; E Puente; L Tang; D Chien; U Hoch; A Choudhury; D Yu; SL Currie; MA Tagliaferri; J Zalevsky; AO Siefker-Radtke; ME Hurwitz

2022

Article

An intra-tumoral niche maintains and differentiates stem-like CD8 T cells

by Caroline S. Jansen; Nataliya Prokhnevska; Viraj Master; Martin Sanda; Jennifer Carlisle; Mehmet Bilen; Maria Cardenas; Scott Wilkinson; Ross Lake; Adam G. Sowalsky; Rajesh M. Valanparambil; William Hudson; Donald McGuire; Kevin Melnick; Amir L. Khan; Kyu Kim; Yun Min Chang; Alice Kim; Christopher Filson; Mehrdad Alemozaffar; Adeboye Osunkoya; Patrick Mullane; Carla Ellis; Rama Akondy; Sejin Im; Alice O. Kamphorst; Adriana Reyes; Yuan Liu; Haydn Kissick

2019

Article

Outcomes With First-Line PD-1/PD-L1 Inhibitor Monotherapy for Metastatic Renal Cell Carcinoma (mRCC): A Multi-Institutional Cohort

by Pedro Barata; Whitley Hatton; Arpita Desai; Vadim Koshkin; Ellen Jaeger; Charlotte Manogue; Patrick Cotogno; Malcolm Light; Brian Lewis; Jodi Layton; Oliver Sartor; Arnab Basu; Deepak Kilari; Hamid Emamekhoo; Mehmet Bilen

2020

Article

Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial

by Mehmet Bilen; TK Choueiri; J Larkin; S Pal; RJ Motzer; B Rini; B Venugopal; B Alekseev; H Miyake; G Gravis; S Hariharan; A Chudnovsky; KA Ching; XJ Mu; M Mariani; PB Robbins; B Huang; A di Pietro; L Albiges

2021